Multiple Manufacturers

VALRUBICIN

Manufacturer:

Multiple Manufacturers

Valrubicin HCPCS:

J9357

HCPCS Code Descriptor:

Injection, valrubicin, intravesical, 200 mg

Category:

J Code

Valrubicin NDCs:

24201-0101-04, 67979-0001-01

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Urinary bladder

Valrubicin CPT Codes:

Potential CPT administration codes for Valrubicin can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

67979-0001-01

About Valrubicin:

VALRUBICIN is a medication manufactured by multiple manufacturers and aligned to the J Code: J9357. VALRUBICIN is administered via the urinary bladder route of administration.

VALRUBICIN is an anticancer medication that belongs to the class of drugs known as anthracyclines. This medication works by slowing down and stopping the growth of cancer cells. VALRUBICIN is often used to treat certain types of bladder cancer. This drug is manufactured by Endo pharmaceuticals, Valera incorporated, and Leucadia pharmaceuticals. VALRUBICIN is aligned to the HCPCS code J9357 and has been since January 2009.

ACCESS PRICING AND MORE BY REGISTERING

J9357 Added Date:

January 1, 2000

J9357 Effective Date:

January 1, 2009

J9357 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Valrubicin billing and coding information.
Our team did not identify a source for Valrubicin patient assistance information. Please reach out to our team if you feel that this is a mistake.
VALRUBICIN prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for VALRUBICIN. Please check back in a few weeks.